Table 1.
Baseline and postprogram characteristics of the MAO and MA-NO phenotype groups who transitioned to metabolically healthy (values are mean ± standard deviation)
| Outcome variable | MAO to MHO (n=27) |
MA-NO to MH-NO (n=15) |
||
|---|---|---|---|---|
| Baseline | Postprogram | Baseline | Postprogram | |
| Absolute EE (kcal · wk−1) | 371±512 | 1,770±552* | 643±549 | 1,425±315* |
| Relative EE (kcal · kg−1 · wk−1) | 3.7±5.0 | 17.9±5.5* | 8.6±7.6 | 19.4±5.2* |
| Waist circumference (cm) | 112.0±13.0 | 109.3±12.5* | 89.2±6.9 | 88.0±7.1 |
| Body mass index (kg/m2) | 34.1±3.8 | 34.0±3.7 | 25.4±3.1 | 25.3±3.2 |
| Body mass (kg) | 101.9±17.9 | 101.4±17.5 | 75.3±8.0 | 74.8±8.0 |
| Systolic BP (mmHg) | 126±11 | 120±9* | 122±11 | 119±8 |
| Diastolic BP (mmHg) | 78±7 | 76±7* | 75±9 | 75±7 |
| Total cholesterol (mmol · L−1) | 4.8±1.2 | 4.8±1.1 | 4.7±1.3 | 4.6±1.1 |
| HDL cholesterol (mmol · L−1) | 1.0±0.3 | 1.1±0.3* | 1.0±0.2 | 1.1±0.3* |
| LDL cholesterol (mmol · L−1) | 2.8±1.0 | 2.7±0.9 | 3.1±1.1 | 3.0±0.9 |
| Triglycerides (mmol · L−1) | 2.0±0.9 | 1.7±0.8* | 1.5±0.7 | 1.4±0.4 |
| Glucose (mmol · L−1) | 5.9±0.9 | 5.4±0.6* | 6.3±0.8 | 5.5±0.5* |
| CR fitness (mL · kg−1 · min−1) | 28.4±7.8 | 32.0±8.6* | 32.2±5.5 | 36.6±6.8* |
| 10-year risk score (%) | 5.5±5.5 | 5.1±5.2 | 5.1±7.0 | 4.7±6.9* |
Notes:
*
P<0.05 for within-group change versus baseline by paired t-test.
Abbreviations: BP, blood pressure; CR, cardiorespiratory; EE, energy expenditure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MA-NO, metabolically abnormal nonobese; MAO, metabolically abnormal obese; MH-NO, metabolically healthy nonobese; MHO, metabolically healthy obese.